These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8608840)

  • 21. Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.
    Burack RC; Wood DP
    Med Clin North Am; 1999 Nov; 83(6):1423-42, vi. PubMed ID: 10584601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for prostate cancer: enthusiasm.
    Catalona WJ
    Urology; 1993 Aug; 42(2):113-5. PubMed ID: 7690167
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
    Hamilton RJ; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer screening with PSA, DRE and TRUS.
    Cusan L
    Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
    [No Abstract]   [Full Text] [Related]  

  • 26. European PSA testing trial update offers little guidance to American men.
    Harv Mens Health Watch; 2012 Jun; 16(11):8. PubMed ID: 22768409
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for prostate cancer--more questions than answers.
    Rietbergen JB; Schröder FH
    Acta Oncol; 1998; 37(6):515-32. PubMed ID: 9860309
    [No Abstract]   [Full Text] [Related]  

  • 28. The science and art of prostate cancer screening.
    Yao SL; Lu-Yao GL
    J Natl Cancer Inst; 2011 Mar; 103(6):450-1. PubMed ID: 21350220
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for prostatic carcinoma.
    Hinman F
    J Urol; 1991 Jan; 145(1):126-9; discussion 129-30. PubMed ID: 1701495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for prostate cancer.
    Waldman AR; Osborne DM
    Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
    Roobol MJ; Schröder FH
    J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J
    J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
    Wroclawski ML
    Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for prostate cancer in a population of South Poland--studies 2000.
    Laskiewicz J; Janik A; Dobrek Ł; Słodowska-Hajduk Z; Matyja A; Thor PJ
    Folia Med Cracov; 2003; 44(1-2):159-68. PubMed ID: 15232898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.
    Schröder FH; Roobol MJ; Damhuis RA; de Koning HJ; Blijenberg BG; Van der Kwast TH; Kirkels WJ; Bangma CH
    J Natl Cancer Inst; 2005 May; 97(9):696. PubMed ID: 15870441
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for prostate cancer: PSA blood test, rectal examination, and ultrasound.
    Moore S; Kuhrik M; Kuhrik N; Shea L
    Urol Nurs; 1992 Sep; 12(3):106-7. PubMed ID: 1382318
    [No Abstract]   [Full Text] [Related]  

  • 38. Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening.
    Ciatto S; Zappa M; Villers A; Paez A; Otto SJ; Auvinen A
    BJU Int; 2003 Dec; 92 Suppl 2():97-100. PubMed ID: 14983964
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection and screening for prostate cancer.
    Lee F; Torp-Pedersen S; Cooner W; Drago J; Holtgrewe L; Littrup P; Resnick M
    Cancer; 1992 Jul; 70(1 Suppl):355-6. PubMed ID: 1376205
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations from the BC Office of Health Technology Assessment.
    Bassett K
    Can J Oncol; 1994 Nov; 4 Suppl 1():86-8; discussion 89-95. PubMed ID: 8853499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.